Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nirland Limited Insider Profile
4 Followers
Nirland Limited, Ten Percent Owner at Conduit Pharmaceuticals, holds 6.09M shares in Conduit Pharmaceuticals (Ticker: CDT). Most recently, Nirland Limited Sold $3,808,000 shares of Conduit Pharmaceuticals on Oct 07, 2024 for an estimated value of 380.80K.
Nirland Limited Conduit Pharmaceuticals (CDT)Ten Percent Owner
Conduit Pharmaceuticals (CDT)
Ten Percent Owner
Ranked #37,655 out of 100,202 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+24.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Nirland Limited holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nirland Limited
Nirland Limited's Trading History
List of latest transactions for each holding click on a transaction to see Nirland Limited's performance on stock
You May Also Like
Nirland Limited insider profile FAQ
What is the percentage of profitable transactions made by Nirland Limited?
The percentage of profitable transactions made by Nirland Limited is 100%.
What is the average return per transaction made by Nirland Limited?
The average return per transaction made by Nirland Limited is 24.00%.
What stocks does Nirland Limited hold?
Nirland Limited holds: CDT stocks.
What was Nirland Limited’s latest transaction?
Nirland Limited latest transaction was an Informative Sell of $380.80K.
What was Nirland Limited's most profitable transaction?
Nirland Limited’s most profitable transaction was an Informative Sell of CDT stock on October 7, 2024. The return on the trade was 26.00%.
What is Nirland Limited's role in Conduit Pharmaceuticals?
Nirland Limited's role in Conduit Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.